Tuesday, September 23, 2014
Go to Market Reports.com
3D Cell Culture: mimicking real tissue
Tecan Group Ltd.
A Fast and Simple Method For Measuring P-Glycoprotein (Pgp) Inhibition
A Fluorescence Based Assay of the Epigenetic Enzyme Histonedeacetylase
Automated Illumina NGS Sample Preparation: TruSeq® Stranded mRNA on th
Automating Aqueous Compound Solubility Using the 96-Well Multiscreen®
Creating dose-response curves for cell-based and biochemical assays wi
Tecan Group Ltd.
DNA Transfection with High Transfection Efficiency and Low Toxicity Us
Dual-Glo Luciferase Reporter-Gene Assay on the SpectraMax M5, LMax II3
Efficient Delivery of siRNA in Human Renal Cell Carcinoma Cell Line Us
showing results 1 to 9 of 21
Promise for Treatment of Pancreatic Cancer
Ultrasound microbubbles can improve tumor absorption of cancer drugs.
Novel Drug Targeting Leukemia Cells Enters Clinical Trial
Phase 1 human clinical trial to assess the safety and efficacy of a new monoclonal antibody for CLL patients.
What Lies Behind the Death of Stem Cells
Researchers have identified key processes that control stem cell survival, providing insights that could improve their use in medicine.
Genetic Testing for Prostate Cancer
Genetic testing can identify men at six-fold increased risk of prostate cancer.
Redefining High Risk Patients With Stage II Colon Cancer
microRNA-21 identified as an independent prognostic biomarker.
Leukemia Subtype Becomes More Common With Age
Genomic Analysis of 1,725 patients reveals the prevalence of Ph-like ALL increases with age.
Ovarian Cancer Oncogene Found in "Junk DNA"
The study is published online in this week in Cancer Cell.
New Genetic Target for a Different Kind of Cancer Drug
Upstream of the proteins that cancer cells use to proliferate sits RBM4, a gene-splicing protein that is drastically reduced in human lung and breast cancer cells.
Combination microRNA Therapy Suppresses Non-Small-Cell Lung Cancer
Findings offer a promising therapeutic avenue for NSCLC.
Breakthrough Melanoma Treatment, Keytruda, Developed
New immunotherapy launched in the US for treatment of adults with advanced melanoma, developed using antibody humanization expertise at UK’s MRC Technology.
Advertise On This Site
Terms & Conditions
©2014 Technology Networks
, all rights reserved.